UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Deep learning predicts cervical lymph node metastasis in clinically node-negative papillary thyroid carcinoma Journal article
Zhou, Li Qiang, Zeng, Shu E., Xu, Jian Wei, Lv, Wen Zhi, Mei, Dong, Tu, Jia Jun, Jiang, Fan, Cui, Xin Wu, Dietrich, Christoph F.. Deep learning predicts cervical lymph node metastasis in clinically node-negative papillary thyroid carcinoma[J]. Insights into Imaging, 2023, 14(1), 222.
Authors:  Zhou, Li Qiang;  Zeng, Shu E.;  Xu, Jian Wei;  Lv, Wen Zhi;  Mei, Dong; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.1/5.9 | Submit date:2024/01/02
Deep Learning  Ln Metastasis Prediction  Papillary Thyroid Cancer  Us Diagnosis  
MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling Journal article
Yufei Jiang, Yarong Liu, Yiyuan Zhang, Jielin Ouyang, Yang Feng, Shumei Li, Jingjing Wang, Chaojie Zhang, Lihong Tan, Jie Zhong, Lianhong Zou. MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK/ERK/PI3K signaling[J]. Cellular Signalling, 2023, 109, 110792.
Authors:  Yufei Jiang;  Yarong Liu;  Yiyuan Zhang;  Jielin Ouyang;  Yang Feng; et al.
Favorite | TC[WOS]:6 TC[Scopus]:8  IF:4.4/4.4 | Submit date:2023/08/03
Fak Signaling  Fn1  Invasion  Mir-142–3p  Thyroid Cancer  
Preparation and evaluation of 131I-quercetin as a novel radiotherapy agent against dedifferentiated thyroid cancer Journal article
Xie,Qinghua, Li,Xia, Wang,Guanquan, Hou,Xuan, Wang,Yujun, Yu,Hongbo, Qu,Changfa, Luo,Shunzhong, Cui,Yali, Xia,Chuanqin, Wang,Ruibing. Preparation and evaluation of 131I-quercetin as a novel radiotherapy agent against dedifferentiated thyroid cancer[J]. Journal of Radioanalytical and Nuclear Chemistry, 2017, 311(3), 1697-1708.
Authors:  Xie,Qinghua;  Li,Xia;  Wang,Guanquan;  Hou,Xuan;  Wang,Yujun; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:1.5/1.5 | Submit date:2021/03/02
131i-quercetin  Biodistribution  Dedifferentiated Thyroid Cancer  Proliferation Inhibition  Radiopharmaceutical  
Preparation and evaluation of I-131-quercetin as a novel radiotherapy agent against dedifferentiated thyroid cancer Journal article
Xie, Qinghua, Li, Xia, Wang, Guanquan, Hou, Xuan, Wang, Yujun, Yu, Hongbo, Qu, Changfa, Luo, Shunzhong, Cui, Yali, Xia, Chuanqin, Wang, Ruibing. Preparation and evaluation of I-131-quercetin as a novel radiotherapy agent against dedifferentiated thyroid cancer[J]. JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2017, 311(3), 1697-1708.
Authors:  Xie, Qinghua;  Li, Xia;  Wang, Guanquan;  Hou, Xuan;  Wang, Yujun; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:1.5/1.5 | Submit date:2018/10/30
Dedifferentiated Thyroid Cancer  I-131-quercetin  Proliferation Inhibition  Biodistribution  Radiopharmaceutical